Outlook of 28 April 2009

Commenting on the results, Feike Sijbesma, chairman of the DSM Managing Board, said: “Ongoing strong performances from our Life Sciences businesses and stringent control of costs and working capital allowed DSM as a whole to remain profitable and cash generating throughout the quarter despite the very challenging economic conditions which primarily affected most of Materials Sciences". (more .....)



Key Figures Q1 2009

Key figures Q1 2009





Current share price



Last :€ 22.30Change:-0.71%
Date:03 Jul 2009Time:17:35

 

News